226.27
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib in Adults and Adolescents with Vitiligo - Investing News Network
AbbVie (ABBV) Reports Promising Results from Phase 3 Studies on RINVOQ for Vitiligo - GuruFocus
Will AbbVie Inc. (Common Stock) (4AB0) stock test record highs in 2025Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) – Clinical Overview, Companies, Therapeutic Assessment, Treatment Approaches, Pipeline Insights | AbbVie, Sanofi - Barchart.com
AbbVie: Deep Discount Before Earnings (NYSE:ABBV) - Seeking Alpha
Should You Buy AbbVie Stock Ahead of Q3 Earnings Report? - sharewise.com
Allergan Aesthetics and Girls Inc., in Partnership with SkinSpirit, Inspire Future Women Leaders in STEM - PR Newswire
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. - The Motley Fool
Will AbbVie Inc. stock attract more institutional investorsEarnings Overview Summary & Capital Protection Trade Alerts - newser.com
Can AbbVie Inc. stock attract analyst upgrades2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Chronic Idiopathic Constipation Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland, Forest - Barchart.com
AbbVie Defends Challenge Of Colorado's Discount Drug Law - Law360
Can AbbVie Inc. stock withstand economic slowdownEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com
Will AbbVie Inc. (Common Stock) (4AB0) stock extend growth storyPortfolio Gains Report & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará
Can AbbVie Inc. stock surprise markets with earningsPortfolio Growth Summary & Real-Time Chart Pattern Alerts - newser.com
What's in Store for These 5 Pharma Bigwigs This Earnings Season? - TradingView
Pigmentation Disorders Treatment Market Is Booming Worldwide 2025-2032 |Abbvie Inc., Edesa Biotech, Inc., Amgen - openPR.com
Is AbbVie Inc. stock a buy on dips2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
Is AbbVie Inc. stock resilient to inflationJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com
Ophthalmic Drugs Market Set for Dynamic Growth with Key Players Abbvie Inc. (Allergan Plc), Alcon, Inc., Novartis AG - openPR.com
Fish Skin Disease Market to Witness Remarkable Growth With GSK - openPR.com
How AbbVie Inc. stock performs in rising dollar environmentWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
How sentiment analysis helps forecast AbbVie Inc.July 2025 Movers & Comprehensive Market Scan Insights - newser.com
Why AbbVie Inc. (4AB) stock stays on top picksPortfolio Risk Summary & Technical Pattern Alert System - newser.com
How the Story for AbbVie Is Evolving After Key Pipeline Wins and Analyst Shifts - Yahoo Finance
AbbVie Stock Forecast: Where Analysts See the Stock Going by 2027 - TIKR.com
AbbVie’s ABBV-932 Study: A New Hope for Bipolar Disorder Treatment? - TipRanks
Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It? - sharewise.com
Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth - sharewise.com
AbbVie (ABBV) Stock Up 28% YTD as New Drug Wins and Analyst Upgrades Fuel Optimism - ts2.tech
Wolfe Research Adjusts AbbVie Price Target to $275 From $235, Maintains Outperform Rating - MarketScreener
United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio - Yahoo Finance
How AbbVie Inc. (Common Stock) (4AB0) stock behaves under inflation pressureEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com
AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):